Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CASH FLOWS

v3.8.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (2,743,800) $ (4,639,900)
Income from equity method joint ventures (15,700)
Income from discontinued operations 3,389,600 423,300
Net Loss from continuing operations (6,133,400) (5,078,900)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 774,800 740,700 [1],[2]
Stock-based compensation expense 246,600 91,500
Non-cash expense for interest 1,147,000 97,100
Provision for doubtful accounts receivable 224,600  
Cost of sale of equipment to joint venture 316,800  
Settlement expense 254,900  
Gain on disposition of asset (25,600)
Impairment of assets 676,000 1,529,000
Changes in operating assets and liabilities:    
Accounts receivable 270,900 (397,400)
Costs in Excess of billings on uncompleted contracts 13,600 190,400
Prepaid expenses and other assets 593,800 296,900
Accounts payable and accrued liabilities (279,800) 1,282,000
Billings in excess of revenue on uncompleted contracts (863,500) 502,900
Customer deposits 21,600  
Deferred revenue (54,600) 800
Payroll taxes payable 4,400 22,800
Net cash used in operating activities (2,786,300) (747,800)
Cash flows from investing activities:    
Purchase of property and equipment (199,800) (163,700)
Proceeds from sale of discontinued operations, net of costs 2,510,900  
Proceeds from the sale of property and equipment 74,300  
Insurance proceeds 59,000
Purchase of intangible assets (18,600) (45,100)
Distributions for notes receivable (300,000)  
Net cash used in investing activities 2,066,800 (149,800)
Cash flows from financing activities:    
Principal payments of notes and capital lease obligations (1,468,000) (863,600)
Payments of related party notes payable and accrued interest   (20,000)
Proceeds from issuance of convertible and short-term debt 1,275,000 1,155,000
Proceeds from issuance of capital leases 88,800  
Proceeds from the extension of warrants 155,500  
Proceeds from the sale of common stock and warrants, net of expenses   454,900
Net cash provided by financing activities 51,300 726,300
Net cash flows from discontinued operations 489,100 173,900
Net decrease in cash (179,100) 2,600
Cash at the beginning of year 233,200 230,600
Cash at the end of year 54,100 233,200
Supplemental disclosures of cash flow information:    
Cash paid for interest 211,600 257,500
Supplemental disclosure of noncash financing and investing activities:    
Financed equipment 88,400  
Financing of insurance premiums $ 438,300 278,600
Discount on convertible debt   97,100
Offset accounts receivable with note payable   $ 68,000
[1] Excludes discontinued operations
[2] Includes depreciation of property, equipment and leasehold improvement and amortization of intangibles